XORTX Therapeutics Inc. (XRTX)
NASDAQ: XRTX · IEX Real-Time Price · USD
1.740
-0.140 (-7.45%)
At close: Jul 19, 2024, 4:00 PM
1.720
-0.020 (-1.15%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
XORTX Therapeutics Employees
As of December 31, 2023, XORTX Therapeutics had 3 total employees, including 2 full-time and 1 part-time employees. The number of employees did not change compared to the previous year.
Employees
3
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,114,989
Market Cap
5.05M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 3 | 0 | - |
| Dec 31, 2022 | 3 | 0 | - |
| Jan 1, 2022 | 3 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Leafly Holdings | 131 |
| IM Cannabis | 95 |
| Biofrontera | 85 |
| Sharps Technology | 57 |
| Intelligent Bio Solutions | 51 |
| BioCardia | 20 |
| Artelo Biosciences | 6 |
| Creative Medical Technology Holdings | 4 |
XRTX News
- 2 months ago - XORTX Reprices Balance of Warrants Issued in Connection with October 2021 US IPO - GlobeNewsWire
- 2 months ago - XORTX Reprices Warrants Issued in Connection with Previous Private Placements - GlobeNewsWire
- 3 months ago - XORTX Announces Publication of Key Research in ADPKD - GlobeNewsWire
- 3 months ago - XORTX Welcomes New Member to the Board of Directors - GlobeNewsWire
- 4 months ago - XORTX Announces New Clinical Advisory Board Member - GlobeNewsWire
- 4 months ago - XORTX Highlights Achievements of 2023 and Preparation for Registration Clinical Trial - GlobeNewsWire
- 5 months ago - XORTX Finalizes $2.7 Million Prospectus Supplement and Concurrent Private Placement for the Offering of Units - GlobeNewsWire
- 6 months ago - XORTX Files an Amended and Restated Prospectus Supplement for the Offering of Units - GlobeNewsWire